Your browser doesn't support javascript.
loading
Stability of isoniazid injection in i.v. solutions.
Lee, Jun H; Moriyama, Brad; Henning, Stacey A; Danner, Robert L; Walsh, Thomas J; Penzak, Scott R; Grimes, George J; Potti, Gopal K.
Afiliação
  • Lee JH; Investigational Drug Management and Research Section, Pharmacy Department, NIH Clinical Center, Bethesda, MD jun.lee@nih.gov.
  • Moriyama B; Pharmacy Department, NIH Clinical Center, Bethesda, MD.
  • Henning SA; Pharmacy Department, NIH Clinical Center, Bethesda, MD.
  • Danner RL; Critical Care Medicine Department, NIH Clinical Center, Bethesda, MD.
  • Walsh TJ; Transplantation-Oncology Infectious Diseases Program, Department of Medicine, Pediatrics, and Microbiology and Infectious Diseases, Weill Cornell Medical Center of Cornell University, New York, NY.
  • Penzak SR; Department of Pharmacotherapy, System College of Pharmacy, University of North Texas, Fort Worth, TX.
  • Grimes GJ; NIH Clinical Center, Bethesda, MD.
  • Potti GK; Investigational Drug Management and Research Section, Pharmacy Department, NIH Clinical Center, Bethesda, MD.
Am J Health Syst Pharm ; 75(10): 622-626, 2018 May 15.
Article em En | MEDLINE | ID: mdl-29748300
ABSTRACT

PURPOSE:

Results of an assessment of the chemical stability of isoniazid injection in 0.9% sodium chloride injection and 5% dextrose injection are reported.

METHODS:

Triplicate solutions of isoniazid (0.5 and 6.0 mg/mL) in the 2 diluents were prepared in ethylene and propylene copolymer i.v. containers and stored under light protection at room temperature (20-25 °C) or under refrigeration (2-8 °C). Standard aliquots were removed from each solution at time points up to 72 hours and analyzed via high-performance liquid chromatography (HPLC). Stability was defined as retention of >90% of the initial isoniazid concentration; pH, osmolality, and visual appearance were assessed.

RESULTS:

Isoniazid 0.5- and 6.0-mg/mL solutions in 0.9% sodium chloride injection were stable for up to 72 hours at room temperature or under refrigeration. HPLC analysis of isoniazid 0.5-mg/mL solutions in 5% dextrose injection revealed a decrease to less than 90% of the initial concentration at 8 hours at room temperature and at 30 hours under refrigeration. Isoniazid 6.0-mg/mL solutions in 5% dextrose injection were stable for 24 hours at room temperature and for 48 hours under refrigeration. The pH, osmolality, and visual appearance of the solutions were not affected.

CONCLUSION:

Isoniazid solutions of 0.5 and 6.0 mg/mL in 0.9% sodium chloride injection were stable under light protection for up to 72 hours when stored at room temperature or under refrigeration. Isoniazid injection was less stable in 5% dextrose injection, especially at a concentration of 0.5 mg/mL at room temperature.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Química Farmacêutica / Composição de Medicamentos / Isoniazida / Antituberculosos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Química Farmacêutica / Composição de Medicamentos / Isoniazida / Antituberculosos Idioma: En Ano de publicação: 2018 Tipo de documento: Article